Buscar
Entera Bio Ltd
ENTXAñadir a la lista de seguimiento
1.660USD
-0.030-1.78%
Cierre 07/02, 13:00（ET）Cotizaciones retrasadas 15 min
77.39MCap. mercado
PérdidaP/E TTM
Más Datos de Entera Bio Ltd Compañía
Entera Bio Ltd is an Israel-based clinical-stage biopharmaceutical company focused on the development and commercialization of orally delivered large molecule therapeutics for use in areas with unmet medical need and where adoption of injectable therapies is limited due to cost, convenience and compliance challenges for patients. The Company developed a platform that enables the oral delivery of injectable proteins and large molecules. Entera Bio candidates are EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism. Both EB613 and EB612 are oral formulations of human parathyroid hormone (1-34), or Parathormon (PTH). The products are administered via injection.
Información de Entera Bio Ltd
Símbolo de cotizaciónENTX
Nombre de la empresaEntera Bio Ltd
Fecha de salida a bolsaJun 28, 2018
Director ejecutivoToledano (Miranda Jayne)
Número de empleados18
Tipo de seguridadOrdinary Share
Fin del año fiscalJun 28
DirecciónHadassah / Jerusalem Bio
CiudadJERUSALEM
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísIsrael
Código postal9112002
Teléfono97225327151
Sitio Webhttps://enterabio.com/
Símbolo de cotizaciónENTX
Fecha de salida a bolsaJun 28, 2018
Director ejecutivoToledano (Miranda Jayne)
Ejecutivos de Entera Bio Ltd
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Miranda Jayne Toledano
Ms. Miranda Jayne Toledano
Chief Executive Officer, Director
Chief Executive Officer, Director
426.57K
--
Mr. Gerald M. (Jerry) Lieberman
Mr. Gerald M. (Jerry) Lieberman
Independent Chairman of the Board
Independent Chairman of the Board
363.25K
+10.54%
Mr. Sean Ellis
Mr. Sean Ellis
Independent Director
Independent Director
188.09K
-0.00%
Ms. Haya Taitel
Ms. Haya Taitel
Independent Director
Independent Director
98.48K
--
Mr. Gerald M. (Jerry) Ostrov
Mr. Gerald M. (Jerry) Ostrov
Independent Director
Independent Director
75.66K
+37.96%
Mr. Yonatan Malca
Mr. Yonatan Malca
Independent Director
Independent Director
59.42K
-30.29%
Dr. Hillel Galitzer
Dr. Hillel Galitzer
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Roger J. Garceau, M.D.
Dr. Roger J. Garceau, M.D.
Director
Director
--
--
Dr. Arthur C. Santora
Dr. Arthur C. Santora
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Dana Yaacov-Garbeli
Ms. Dana Yaacov-Garbeli
Chief Financial Officer
Chief Financial Officer
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Miranda Jayne Toledano
Ms. Miranda Jayne Toledano
Chief Executive Officer, Director
Chief Executive Officer, Director
426.57K
--
Mr. Gerald M. (Jerry) Lieberman
Mr. Gerald M. (Jerry) Lieberman
Independent Chairman of the Board
Independent Chairman of the Board
363.25K
+10.54%
Mr. Sean Ellis
Mr. Sean Ellis
Independent Director
Independent Director
188.09K
-0.00%
Ms. Haya Taitel
Ms. Haya Taitel
Independent Director
Independent Director
98.48K
--
Mr. Gerald M. (Jerry) Ostrov
Mr. Gerald M. (Jerry) Ostrov
Independent Director
Independent Director
75.66K
+37.96%
Mr. Yonatan Malca
Mr. Yonatan Malca
Independent Director
Independent Director
59.42K
-30.29%
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Entera Bio Ltd?
Los cinco principales accionistas de Entera Bio Ltd son: Ms. Miranda Jayne Toledano
¿Cuántas instituciones poseen acciones de Entera Bio Ltd (ENTX)?
A fecha de 2026Q1, 34 instituciones poseen acciones de Entera Bio Ltd, con un valor de mercado combinado de aproximadamente 9.31M, lo que representa el 17.10% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -4212.00.